Table 1 Descriptive statistics of cohorts S1 to S5
From: Long-term time trends in reactivated herpes simplex infections and treatment in Sweden
Cohorts | S1 | S2 | S3 | S4 | S5 |
|---|---|---|---|---|---|
n | 764 | 774 | 638 | 278 | 425 |
Age range, y* | 35–91 | 35–81 | 59–90 | 60–91 | 35–95 |
Age, y, mean ± SDa | 61.7 ± 14.1 | 59.9 ± 14.0 | 69.8 ± 9.0 | 74.1 ± 9.2 | 62.9 ± 16.0 |
Female, n (%) | 411 (53.8) | 436 (56.3) | 376 (58.9) | 139 (50.0) | 218 (51.3) |
APOEε4 carriers, n (%) | 227 (29.7%) | 226 (29.2%) | 183 (28.7%) | 72 (25.9%) | 89 (20.9%) |
Sampling year, n Anti-HSV IgM positive samples/n (%) | |||||
T1: 1988–1990 | 30/590 (5.1) | ||||
T2: 1993–1995 | 12/454 (2.6) | 30/774 (3.9) | 17/492 (3.5) | ||
T3: 1998–2000 | 27/381 (7.1) | 29/471 (6.2) | 9/278 (3.2) | ||
T4: 2003–2005 | 3/339 (0.9) | 1/386 (0.3) | 3/425 (0.7) | ||
T5: 2008–2010 | 1/246 (0.4) | 1/222 (0.5) | |||
First sample, n anti-HSV IgM positive samples/n (%) | 35/764 (4.6) | 30/774 (3.9) | 19/638 (3.0) | 9/278 (3.2) | 3/425 (0.7) |